1. Eggerickx D, Denef JF, Labbe O, et al. Molecular cloning of an orphan G-protein- coupled receptor that constitutively activates adenylate cyclase. Biochem J. 1995;309(Pt 3):837e843.
2. Ikawa F, Tanaka S, Harada K, Hide I, Maruyama H, Sakai N. Detailed neuronal distribution of GPR3 and its co-expression with EF-hand calcium-binding proteins in the mouse central nervous system. Brain Res. 2021;1750:147166.
3. Mehlmann LM, Saeki Y, Tanaka S, et al. The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science. 2004;306(5703):1947e1950.
4. Tanaka S, Ishii K, Kasai K, Yoon SO, Saeki Y. Neural expression of G protein- coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth. J Biol Chem. 2007;282(14):10506e10515.
5. Tanaka S, Shimada N, Shiraki H, et al. GPR3 accelerates neurite outgrowth and neuronal polarity formation via PI3 kinase-mediating signaling pathway in cultured primary neurons. Mol Cell Neurosci. 2021:103691.
6. Tanaka S, Miyagi T, Dohi E, et al. Developmental expression of GPR3 in rodent cerebellar granule neurons is associated with cell survival and protects neurons from various apoptotic stimuli. Neurobiol Dis. 2014;68:215e227.
7. Thathiah A, Spittaels K, Hoffmann M, et al. The orphan G protein-coupled re- ceptor 3 modulates amyloid-beta peptide generation in neurons. Science. 2009;323(5916):946e951.
8. Hecker M, Paap BK, Goertsches RH, et al. Reassessment of blood gene expres- sion markers for the prognosis of relapsing-remitting multiple sclerosis. PLoS One. 2011;6(12), e29648.
9. Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Taske´n K. Molecular mecha-nisms for protein kinase A-mediated modulation of immune function. Cell Signal. 2002;14(1):1e9.
10. Conche C, Boulla G, Trautmann A, Randriamampita C. T cell adhesion primes antigen receptor-induced calcium responses through a transient rise in aden- osine 3',5'-cyclic monophosphate. Immunity. 2009;30(1):33e43.
11. Henney CS, Lichtenstein LM. The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol. 1971;107(2):610e612.
12. Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol. 2005;35(1):31e41.
13. Tamir A, Granot Y, Isakov N. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J Immunol. 1996;157(4):1514e1522.
14. Vang AG, Housley W, Dong H, et al. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac. Biochem J. 2013;456(3):463e473.
15. Vang T, Abrahamsen H, Myklebust S, Horejsi V, Tasken K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell re- ceptor signaling. J Biol Chem. 2003;278(20):17597e17600.
16. Ohta A, Ohta A, Madasu M, et al. A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microen- vironments. J Immunol. 2009;183(9):5487e5493.
17. Vang AG, Ben-Sasson SZ, Dong H, et al. PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER. PLoS One. 2010;5(8):e12011.
18. Wells AD. New insights into the molecular basis of T cell anergy: anergy fac- tors, avoidance sensors, and epigenetic imprinting. J Immunol. 2009;182(12): 7331e7341.
19. Bopp T, Becker C, Klein M, et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med. 2007;204(6): 1303e1310.
20. Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal. 2006;4:e002.
21. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesen- cephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A. 1998;95(7):4013e4018.
22. Zetterstro€m RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 1997;276(5310):248e250.
23. Sekiya T, Kashiwagi I, Yoshida R, et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol. 2013;14(3):230e237.
24. Sekiya T, Kashiwagi I, Inoue N, et al. The nuclear orphan receptor Nr4a2 in- duces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun. 2011;2:269.
25. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5(10):772e782.
26. Tetradis S, Bezouglaia O, Tsingotjidou A. Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology. 2001;142(2):663e670.
27. Smith AG, Luk N, Newton RA, Roberts DW, Sturm RA, Muscat GE. Melanocortin- 1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J Biol Chem. 2008;283(18): 12564e12570.
28. Miyagi T, Tanaka S, Hide I, Shirafuji T, Sakai N. The subcellular dynamics of the gs-linked receptor GPR3 contribute to the local activation of PKA in cerebellar granular neurons. PLoS One. 2016;11(1):e0147466.
29. Maira M, Martens C, Philips A, Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol. 1999;19(11):7549e7557.
30. Philips A, Lesage S, Gingras R, et al. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol. 1997;17(10):5946e5951.
31. Cheng LE, Chan FK, Cado D, Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 1997;16(8): 1865e1875.
32. Lith SC, van Os BW, Seijkens TTP, de Vries CJM. Nur'turing tumor T cell toler- ance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity. Eur J Immunol. 2020;50(11):1643e1652.
33. Amsen D, Revilla Calvo C, Osborne BA, Kruisbeek AM. Costimulatory signals are required for induction of transcription factor Nur77 during negative se- lection of CD4(+)CD8(+) thymocytes. Proc Natl Acad Sci U S A. 1999;96(2): 622e627.
34. Pirih FQ, Nervina JM, Pham L, Aghaloo T, Tetradis S. Parathyroid hormone in- duces the nuclear orphan receptor NOR-1 in osteoblasts. Biochem Biophys Res Commun. 2003;306(1):144e150.
35. Newton RA, Roberts DW, Leonard JH, Sturm RA. Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides. 2007;28(12):2387e2396.
36. Oh S, Shin JH, Jang EJ, et al. Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation. Biochem Biophys Res Commun. 2016;474(2): 345e350.
37. Torii T, Kawarai T, Nakamura S, Kawakami H. Organization of the human orphan nuclear receptor Nurr1 gene. Gene. 1999;230(2):225e232.
38. Murphy EP, Conneely OM. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol. 1997;11(1):39e47.
39. Saxena M, Williams S, Taske´n K, Mustelin T. Crosstalk between cAMP- dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol. 1999;1(5):305e311.
40. Brudvik KW, Taske´n K. Modulation of T cell immune functions by the prosta- glandin E(2) - cAMP pathway in chronic inflammatory states. Br J Pharmacol. 2012;166(2):411e419.
41. Mahic M, Yaqub S, Johansson CC, Taske´n K, Aandahl EM. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol. 2006;177(1): 246e254.
42. Montarolo F, Martire S, Perga S, Bertolotto A. NURR1 impairment in multiple sclerosis. Int J Mol Sci. 2019;20(19).